Stocks · Health care · Biological Products, (No Diagnostic Substances)

Entera Bio Ltd.

ENTX Clue Score37
Israel Fiscal year ends December CIK 0001638097 Results filed 6 Nov 2026

What the insiders did Net buying

By person

11 insiders · 8 transactions

There is no salary here to measure against. Entera Bio Ltd.'s chief executive is paid a token, so dividing a holding by it says nothing.

Which is why this company is in neither direction of the chief executive filter on the transactions page. A stake that cannot be expressed as a multiple is not the same thing as a small one.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Geno J Germano
Director
$55.80K (2)
—
+$55.80K
65,014
$84.52K
+225.1%
Sean Ellis
Director
$34.62K (2)
—
+$34.62K
208,132
$270.57K
+63.1%
Miranda Jayne Toledano
Chief Executive Officer
$19.91K (1)
—
+$19.91K
847,135
$1.10M
+260.7%
Steven D Rubin
Director
$19.45K (2)
—
+$19.45K
34,117
$44.35K
—
Haya Taitel
Director
$11.10K (1)
—
+$11.10K
119,269
$155.05K
+82.8%
Gerald M Lieberman
Director
—
—
—
338,454
$439.99K
+27.5%
Gregory Burshtein
Chief of R&D
—
—
—
189,033
$245.74K
+151.6%
Dana Yaacov-Garbeli
Chief Financial Officer
—
—
—
171,441
$222.87K
+97.7%
Hillel Galitzer
Chief Operating Officer
—
—
—
163,566
$212.64K
+154.5%
Yonatan Malca
Director
—
—
—
100,231
$130.30K
+156.7%
Gerald M Ostrov
Director
—
—
—
75,657
$98.35K
+94.5%

No percentages here. This company's share count has moved by a factor of 3.8 over the window, from 45,420,676 to 173,141,831 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.